Toggle navigation
Home
Search
Services
Blog
Contact
About
Clin Trials & Clin Markers for Immunologic Diseases-266005411
Brigham and Women's Hospital, Boston, MA, United States
Search grants from Brigham and Women's Hospital
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Computer Aided Detection for CT Colonography
Infection Biology Training Grant
Modification of host proteins during Chlamydia infection
Rocky Mountain Cancer Genetics Coalition
Fine-Scale Crustal Structure of the Kane Fracture Zone in 0-80 M.Y.-Old Crust
Recently added grants:
Mechanisms of COPII-Dependent Quality Control and ER Export
Milton/Trak 1/2 Protein and the Transport of Mitochondria
Development of a Broad-Spectrum Inhibitor against Seasonal and Highly-Pathogenic Influenza Viruses
Regulation of mRNA translation during germline cyst differentiation
The evolution of genomic imprinting
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI005411-001
Application #
6688689
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 2002
N01 AI
Clin Trials & Clin Markers for Immunologic Diseases-266005411
/ Brigham and Women's Hospital
NIH 2000
N01 AI
Clin Trials & Clin Markers for Immunologic Diseases
Weiner, Howard L. / Brigham and Women's Hospital
$646,654
Publications
Kivisakk, P; Healy, B C; Viglietta, V et al.
(2009)
Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells.
Neurology 72:1922-30
Comments
Be the first to comment on this grant